Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Use advanced search instead (articles only)
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Other Conditions
Vol. 2, Issue 2, 2015
July 15, 2015 EDT
Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
Mike Durkin
,
Jacqueline Pesa
,
Jessica Lopatto
,
Rachel Halpern
,
Damon Van Voorhis
,
Stephanie Korrer
,
oxycodone cr
tapentadol er
resource use
health care costs
chronic pain
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9905
Photo by
Simone van der Koelen
on
Unsplash
JHEOR
1.
Durkin M, Pesa J, Lopatto J, Halpern R, Van Voorhis D, Korrer S. Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR.
JHEOR
. 2015;2(2):221-232.
doi:10.36469/9905
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats